Evolving Technology Platforms in Pharma-Biotech
|出版商||Frost & Sullivan||商品編碼||346463|
|出版日期||內容資訊||英文 87 Pages
本報告提供生物醫藥品的開發相關調查分析，以藥物研發初期階段之後的藥物為焦點，R&D組合與預算分析，環境分析 (技術性課題，商務課題，新興市場需求) 、產業的最佳業務實踐與策略性考察 (業績，合作夥伴關係、聯盟，研發產品線等) 、R&D組合的策略性評估相關的系統性資訊。
The road ahead toward precision medicine
The continued development of new treatments associated with the demographic trends and public health considerations is essential. The biopharmaceutical industry is one of the most research intensive sectors in developed nations. Investments are more than USD 125 billion, especially in early stages development phases, including the processes of discovering and developing new medicines.
Biopharmaceutical innovation has played a major role in the improvement of both length and quality of life during the past decade, considerably reducing the disease burden for individuals and the society. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for precision medicine for the upcoming years. Indeed, the promise of personalized medicine is becoming a reality generating notable improvements in human health and the potential to reduce the socioeconomic burden of disease.
This research service (RS) depicts the current landscape of biopharmaceutical development, focusing on medicines that have progressed beyond early stage development and have recently entered clinical testing in human volunteers or first-in-human studies.